What AnyBio does

AnyBio (legal entity Any Biosignal, Inc.) is a biosignal infrastructure platform that operates a governed agentic layer between wearable monitoring devices and clinical care. The company is a privately held Delaware corporation headquartered at 2261 Market Street in San Francisco, founded and led by CEO Stephen Saine. It serves four primary customer segments: risk-bearing healthcare providers and health systems running remote patient monitoring or prevention programs; clinical trial sponsors and research teams conducting multi-device studies; AI/ML, SaMD, and DSP companies that need to reach providers through neutral rails; and device builders seeking compliant distribution channels.

The platform captures biosignals from BLE wearables via the BioSDK for iOS and from a catalog of 60+ FDA-cleared cellular devices, processes them through server-side digital signal processing pipelines (including Pan-Tompkins ECG-to-heart-rate and pulse-foot PPG-to-heart-rate extractors, Butterworth filters, peak detection, and FFT), and delivers FHIR R4 observations with US Core Vitals to EHR systems, alongside HL7v2 interface feeds. Additional platform components include a Model Registry for versioned ML model deployment, a private-preview Algorithm Marketplace for cryptographically signed third-party DSP algorithms, BioUI Web components for browser-based health visualizations, and a Program Builder Agent that uses conversational AI to translate natural-language detection criteria into configured programs. The infrastructure runs on Google Cloud Platform and is SOC 2 Type II and HIPAA compliant.

AnyBio generates revenue through three commercial offerings priced via working sessions: an ROI-discovery pilot that overlays the agentic layer on existing RPM footprints, a complete monitoring deployment that ships devices and runs the governed layer from the first patient, and a sponsor-funded clinical study delivered on the same rails. Pricing combines a recurring platform fee covering the compliance foundation, processor-of-record role, BAAs, and audit infrastructure with usage-based scaling tied to actual patient deployment. The go-to-market pairs enterprise field sales (working sessions) with API-first developer self-service via BioSDK, BioUI Web components, and REST endpoints, with token-based authentication for organization, project, and SDK access.

Name

AnyBio

Legal name

Any Biosignal, Inc.

Website

https://anybio.io

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

AnyBio operates a governed agentic biosignal infrastructure platform that captures data from BLE wearables and 60+ FDA-cleared devices, processes it through DSP pipelines, and delivers FHIR-native data to EHRs for healthcare providers, clinical trial sponsors, and AI/device companies.

Ownership category

akta.pro rank

Product category

Healthcare Biosignal Infrastructure

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

akta.pro secondary industries

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Biosignal infrastructure
• Remote patient monitoring
• Digital signal processing
• Clinical AI governance
• FHIR interoperability

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Infrastructure, Personnel, Operations, Marketing or Sales

Revenue model

1. Platform Fee: Platform fee covers compliance foundation, governed environment, processor-of-record role, audit, and BAAs. This is a fixed recurring cost that exists before patient monitoring begins.
2. Usage-Based Scaling: Usage scales with actual deployment - real deployment determines cost proportional to what is running. A first program of a few hundred patients and a full deployment of tens of thousands run on the same rails with usage-based pricing.
3. ROI-Discovery Pilot: Working session-based engagement where the governed agentic layer goes on top of existing monitoring footprint to measure prevention's effect on admissions and cost. No rip-and-replace required.
4. Complete Monitoring Deployment: Full deployment from device catalog including devices shipped to patients, signal captured into governed layer, and ROI measurement running from first patient.
5. Sponsor-Funded Clinical Study: Multi-device, auditable data collection with provenance throughout, structured for analysis pipeline. Provider site participates without holding PHI.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

AnyBio provides a governed agentic biosignal infrastructure platform that captures biosignals from BLE wearables through BioSDK and 60+ FDA-cleared cellular devices, processes them through server-side DSP pipelines, and delivers FHIR R4-compliant data to EHR systems. The platform adds an AI-powered middleware layer with signal prioritization, early deterioration surfacing, follow-up coordination, and ROI measurement for healthcare providers running remote patient monitoring and prevention programs. Offerings include an ROI-discovery pilot overlay, complete monitoring deployment, and sponsor-funded clinical studies, all running on HIPAA and SOC 2 Type II compliant infrastructure built on Google Cloud Platform.

Product overview

AnyBio is a biosignal infrastructure platform offering a governed agentic layer that sits between monitoring data and clinical action. The core portfolio spans device connectivity via BioSDK (iOS) and 60+ FDA-cleared cellular devices, server-side digital signal processing (DSP) for ECG/PPG/EDA feature extraction, the BioUI Web widget library for browser-based health visualizations, a Model Registry for ML model versioning and deployment, an Algorithm Marketplace for third-party DSP algorithms, FHIR R4-native EHR interoperability, and a Program Builder Agent for conversational clinical program design. The platform delivers ROI-discovery pilots that overlay existing RPM programs, complete monitoring deployments from device catalog, and sponsor-funded clinical studies—all running on neutral, governed rails with HIPAA and SOC 2 Type II compliance.

Differentiator

Problem solved

Functional benefit

Products and services

• Governed Agentic Layer AI-powered middleware platform that adds signal prioritization, early deterioration surfacing, follow-up coordination, and ROI measurement to existing or new RPM programs, with BAA-compliant model routing, wellness-or-clinical policy enforcement, bounded agent authority, and full audit trails.
• AnyBio Complete Monitoring Deployment End-to-end remote patient monitoring deployment using 60+ FDA-cleared cellular devices from AnyBio's catalog. Devices ship to patients, signals are captured into the governed layer, and ROI measurement runs from the first patient.
• ROI Discovery Pilot Overlay engagement that places the governed agentic layer on top of an existing remote patient monitoring footprint to measure prevention's effect on admissions and cost across a risk pool without rip-and-replace.
• Sponsor-Funded Study on the Rails Multi-device auditable data collection with full provenance for clinical study sponsors, structured for sponsor analysis pipelines with PHI held by the provider site rather than the sponsor.
• BioSDK iOS software development kit distributed via Swift Package Manager that handles BLE device discovery, connections, and reliable delivery of biosignal streams (ECG, PPG, EDA, temperature, heart rate) from wearables to the AnyBio platform.
• BioUI Web Framework-agnostic browser widget library built on Web Components and Lit, distributed via CDN with zero build step. Drop-in components include bio-health-metrics, bio-checkin, bio-mood, bio-journal, bio-task-list, and bio-progress-ring for digital health applications.
• Model Registry Versioned catalog for machine learning models that process biosignal data, supporting registration, versioning, deployment against live or historical session data, and performance monitoring for ECG, PPG, and EDA inputs.
• DSP (Digital Signal Processing) Layer Server-side signal processing service that turns raw biosignal streams into clean time-aligned features, with generic primitives (Butterworth filters, peak detection, FFT) and modality extractors such as ECG-to-HR via Pan-Tompkins and PPG-to-HR via pulse-foot detection.
• Algorithm Marketplace Private preview platform for running cryptographically signed third-party DSP algorithms against biosignal streams inside AnyBio's governed sandbox, with signature verification at execution time.
• FHIR Integration FHIR R4-native interoperability service with LOINC-coded observations, FHIR Bundle export, UCUM-aligned units, US Core Vitals profile support, and Provenance resources linking observations to source device sessions.
• Program Builder Agent Conversational AI assistant with a streaming SSE interface that helps design clinical detection programs from natural-language descriptions of biosignal patterns and episode triggers.

Quantifiable outcome

• 74-99% of physiological-monitor alerts are non-actionable (published research cited)
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability5 records

Feature8 records

Partnerships

Five partnerships are on record, tiered core.

• Device Catalog Partners (60+ FDA-cleared cellular device manufacturers)coreTechnology or IntegrationPartnership with 60+ FDA-cleared cellular device manufacturers enabling AnyBio customers to deploy from a device catalog. AnyBio serves as the neutral rail connecting device data to providers' governed environment.
• FitbitcoreTechnology or IntegrationFitbit OAuth integration through bio-health-metrics widget, allowing users to connect Fitbit accounts and sync health metrics including steps, sleep, heart rate, HRV, stress, active minutes, and calories.
• DexcomcoreTechnology or IntegrationDexcom continuous glucose monitor integration mentioned in bio-health-metrics roadmap for additional providers.
• Algorithm Marketplace PublisherscoreTechnology or IntegrationThird-party DSP algorithm vendors publishing signed binaries to the AnyBio marketplace. Vendors retain IP while customers run algorithms against their streams inside AnyBio's governed sandbox.
• Google Cloud PlatformcoreTechnology or IntegrationInfrastructure provider for AnyBio platform. Services used include Cloud DNS, Cloud Pub/Sub, Cloud SQL, Cloud Storage, Identity & Access Management, Cloud KMS, Cloud Machine Learning, and Cloud Developer Tools.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Validic: Validic is a healthcare data connectivity platform that aggregates biometric and clinical data from 700+ consumer and clinical devices and delivers it to EHRs and analytics platforms. It is the closest direct peer to AnyBio's neutral-rail biosignal infrastructure and 60+ FDA-cleared device catalog positioning.
• Redox: Redox is a healthcare API and integration platform used by digital health developers to send and receive clinical data to EHRs via FHIR/HL7. Comparable to AnyBio as an interoperability and developer-first platform layer between health apps and provider record systems.
• Human API: Human API is a consumer health data network that aggregates medical records, wearable, and lab data through a single API for digital health, clinical research, and insurance customers. Directly comparable to AnyBio's API-first, multi-device biosignal aggregation approach.
• CareEvolution: CareEvolution provides the HIEBus platform for clinical data aggregation, FHIR-based interoperability, and remote patient monitoring integrations. Comparable as an interoperability and RPM data-infrastructure layer connecting devices, payers, providers, and EHRs.
• Rimidi: Rimidi is a clinical management platform combining EHR data, device data, and patient-generated health data for chronic disease management. Directly comparable to AnyBio's provider-facing, device-agnostic RPM and prevention program focus.
• Vivify Health (Optum): Vivify Health (acquired by Optum) is one of the earliest end-to-end remote patient monitoring platforms spanning device kits, patient engagement, and clinician workflows. Comparable to AnyBio on the complete-monitoring-deployment product and the provider-targeted prevention use case.
• 100Plus (Preventice Solutions): 100Plus is a remote patient monitoring platform offering connected devices (blood pressure cuff, glucometer, weight scale, etc.) with clinician dashboards and AI-powered alerts. Directly comparable to AnyBio's complete-monitoring-deployment offering and FDA-cleared device catalog approach.
• Medable: Medable is a decentralized clinical trial platform for eCOA/ePRO, connected devices, and remote data capture. Comparable to AnyBio's sponsor-funded clinical study offering with multi-device auditable data collection and provenance.

Broad incumbents

• Apple Health (HealthKit / Health Records): Apple HealthKit is a consumer health data platform on iOS that aggregates wearable, medical record, and clinical data. It is a broad incumbent that AnyBio must integrate with rather than compete against for consumer-side device connectivity, but could in principle extend into the clinical rails AnyBio currently serves.
• Epic Systems: Epic is the dominant US EHR vendor and has growing native RPM, AI, and interoperability capabilities. It is the broad incumbent that AnyBio's platform connects into and competes against for deep clinical workflow ownership in large health systems.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AnyBio